| Dr Scott A Hamlin, MD | |
|
2122 Manchester Expy, Columbus, GA 31904-6878 | |
| (706) 320-2773 | |
| Not Available |
| Full Name | Dr Scott A Hamlin |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 15 Years |
| Location | 2122 Manchester Expy, Columbus, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407099039 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 71765 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Emory University Hospital | Atlanta, GA | Hospital |
| Emory University Hospital Midtown | Atlanta, GA | Hospital |
| Saint Joseph's Hospital Of Atlanta, Inc | Atlanta, GA | Hospital |
| Grady Memorial Hospital | Atlanta, GA | Hospital |
| Emory Johns Creek Hospital | Johns creek, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emory Medical Care Foundation Inc | 4981501814 | 801 |
| The Emory Clinic, Inc | 8820901408 | 2687 |
News Archive
Wake Forest Baptist Medical Center today announced the creation of a Technology Development Program, a $15 million program to develop the ideas, discoveries and inventions of the faculty and staff of the Medical Center into life science technologies having the potential to benefit patients in the community and worldwide.
Preclinical experiments led by a team of researchers at VCU Massey Cancer Center have shown that blocking the production of a protein known as chromodomain helicase DNA-binding protein 4 (CHD4) may help increase the effectiveness of first-line treatments for acute myeloid leukemia (AML), a particularly lethal blood cancer that is increasing in incidence among older adults.
Men with higher exposure to the substance DEHP, a so-called phthalate, have lower sperm motility and may therefore experience more difficulties conceiving children, according to a Lund University study.
Northwestern Medicine-, Walgreens, Alliance of Chicago community health centers and Merck are collaborating on a study with a deceptively simple goal: provide clear instructions on prescription medicine labels so patients don't make mistakes and overcomplicate taking their daily medications.
› Verified 2 days ago
| Entity Name | The Emory Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396798229 PECOS PAC ID: 8820901408 Enrollment ID: O20031110000503 |
News Archive
Wake Forest Baptist Medical Center today announced the creation of a Technology Development Program, a $15 million program to develop the ideas, discoveries and inventions of the faculty and staff of the Medical Center into life science technologies having the potential to benefit patients in the community and worldwide.
Preclinical experiments led by a team of researchers at VCU Massey Cancer Center have shown that blocking the production of a protein known as chromodomain helicase DNA-binding protein 4 (CHD4) may help increase the effectiveness of first-line treatments for acute myeloid leukemia (AML), a particularly lethal blood cancer that is increasing in incidence among older adults.
Men with higher exposure to the substance DEHP, a so-called phthalate, have lower sperm motility and may therefore experience more difficulties conceiving children, according to a Lund University study.
Northwestern Medicine-, Walgreens, Alliance of Chicago community health centers and Merck are collaborating on a study with a deceptively simple goal: provide clear instructions on prescription medicine labels so patients don't make mistakes and overcomplicate taking their daily medications.
› Verified 2 days ago
| Entity Name | Emory Medical Care Foundation Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063452381 PECOS PAC ID: 4981501814 Enrollment ID: O20031217000968 |
News Archive
Wake Forest Baptist Medical Center today announced the creation of a Technology Development Program, a $15 million program to develop the ideas, discoveries and inventions of the faculty and staff of the Medical Center into life science technologies having the potential to benefit patients in the community and worldwide.
Preclinical experiments led by a team of researchers at VCU Massey Cancer Center have shown that blocking the production of a protein known as chromodomain helicase DNA-binding protein 4 (CHD4) may help increase the effectiveness of first-line treatments for acute myeloid leukemia (AML), a particularly lethal blood cancer that is increasing in incidence among older adults.
Men with higher exposure to the substance DEHP, a so-called phthalate, have lower sperm motility and may therefore experience more difficulties conceiving children, according to a Lund University study.
Northwestern Medicine-, Walgreens, Alliance of Chicago community health centers and Merck are collaborating on a study with a deceptively simple goal: provide clear instructions on prescription medicine labels so patients don't make mistakes and overcomplicate taking their daily medications.
› Verified 2 days ago
| Entity Name | Clinch County Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861478851 PECOS PAC ID: 7416849922 Enrollment ID: O20040329000922 |
News Archive
Wake Forest Baptist Medical Center today announced the creation of a Technology Development Program, a $15 million program to develop the ideas, discoveries and inventions of the faculty and staff of the Medical Center into life science technologies having the potential to benefit patients in the community and worldwide.
Preclinical experiments led by a team of researchers at VCU Massey Cancer Center have shown that blocking the production of a protein known as chromodomain helicase DNA-binding protein 4 (CHD4) may help increase the effectiveness of first-line treatments for acute myeloid leukemia (AML), a particularly lethal blood cancer that is increasing in incidence among older adults.
Men with higher exposure to the substance DEHP, a so-called phthalate, have lower sperm motility and may therefore experience more difficulties conceiving children, according to a Lund University study.
Northwestern Medicine-, Walgreens, Alliance of Chicago community health centers and Merck are collaborating on a study with a deceptively simple goal: provide clear instructions on prescription medicine labels so patients don't make mistakes and overcomplicate taking their daily medications.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Scott A Hamlin, MD Po Box 9263, Columbus, GA 31908-9263 Ph: (706) 320-2773 | Dr Scott A Hamlin, MD 2122 Manchester Expy, Columbus, GA 31904-6878 Ph: (706) 320-2773 |
News Archive
Wake Forest Baptist Medical Center today announced the creation of a Technology Development Program, a $15 million program to develop the ideas, discoveries and inventions of the faculty and staff of the Medical Center into life science technologies having the potential to benefit patients in the community and worldwide.
Preclinical experiments led by a team of researchers at VCU Massey Cancer Center have shown that blocking the production of a protein known as chromodomain helicase DNA-binding protein 4 (CHD4) may help increase the effectiveness of first-line treatments for acute myeloid leukemia (AML), a particularly lethal blood cancer that is increasing in incidence among older adults.
Men with higher exposure to the substance DEHP, a so-called phthalate, have lower sperm motility and may therefore experience more difficulties conceiving children, according to a Lund University study.
Northwestern Medicine-, Walgreens, Alliance of Chicago community health centers and Merck are collaborating on a study with a deceptively simple goal: provide clear instructions on prescription medicine labels so patients don't make mistakes and overcomplicate taking their daily medications.
› Verified 2 days ago
Dr. Nishant Michael De Quadros, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 710 Center St, The Medical Center, Columbus, GA 31901 Phone: 706-501-1000 | |
Christopher Leon Mcintire, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 616 19th St, Doctors Hospital, Columbus, GA 31901 Phone: 706-494-4282 Fax: 706-494-4459 | |
Dr. George M Benashvili, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 710 Center St, Department Of Radiology, Columbus, GA 31901 Phone: 706-571-1064 Fax: 706-571-1986 | |
Douglas W Wallace, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 2300 Manchester Expy, Ste A001, Columbus, GA 31904 Phone: 706-257-7700 Fax: 706-257-7708 | |
Dr. Gilbert Orson Maulsby, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 7629 River Crest Dr, Columbus, GA 31904 Phone: 706-641-8272 | |
Robert L Garnett, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 2122 Manchester Expy, St Francis Hospital, Columbus, GA 31904 Phone: 706-596-4115 Fax: 706-596-4119 | |
Dr. Glen Andrew Vahjen, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 710 Center St, Department Of Radiology, Columbus, GA 31901 Phone: 706-571-1064 Fax: 706-571-1986 |